1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6CB1E9A29441A007C8525830E006718D3
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/CB1E9A29441A007C8525830E006718D3!OpenDocument
18
19OpenDocument
2018.97.14.90
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Digital Technology » Cross-Functional Digital Transformation

Document Excerpt: Driving the Value of Digital Initiatives in Medical Affairs: Channel Activities and Challenges

DB Image

ID: MD-625


Features:

11 Info Graphics

13 Data Graphics

250+ Metrics


Pages/Slides: 4


Published: Pre-2020


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt" on the right.


To return to the study abstract to purchase the full study - click here

This excerpt includes research findings and metrics from document #5525 "Driving the Value of Digital Initiatives in Medical Affairs: Channel Activities and Challenges".


Industries Profiled:
Pharmaceutical; Health Care; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Clinical Research; Laboratories; Communications


Companies Profiled:
Novartis; Boehringer Ingelheim; AstraZeneca; Merck; GlaxoSmithKline ; Bayer; Allergan; Abbott; EMD Serono; GE Healthcare; Sanofi; Roche; Pfizer; Shire; Novo Nordisk; MSD; Astellas; Santen; Jazz Pharmaceuticals; Eisai; Sanofi Pasteur; Vifor Pharma; Alkermes; Sanofi Genzyme; Sunovion; ViiV Healthcare; Sage Therapeutics; Seqirus; Incyte; Chiesi; Heron Therapeutics; Ipsen; Ferring Pharmaceuticals; ApotheCom; Indegene

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.